Race Oncology Limited (RAONF) has a profit margin of -262.69%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), RAONF shows a profit margin of -262.69%. That compares with -297.92% in the prior-year period — up 11.8% year over year. That is below the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, RAONF's profit margin is now -262.69% (was -297.92%) — a 11.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Race Oncology Limited is outperforming or lagging.
The Healthcare sector average profit margin is about 17.63%. Race Oncology Limited is at -262.69%, which is lower that average. That is roughly 1590.2% below the sector mean. Use the comparison chart on this page to see how RAONF stacks up against individual peers as well.
That compares with -297.92% in the prior-year period — up 11.8% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Race Oncology Limited with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Race Oncology Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -262.69%) with ownership activity and broader fundamentals.